Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 1346-1355, 2006. First published May 18, 2006; 10.1373/clinchem.2005.065631
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 065631.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2005.065631v1
52/7/1346    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quintela, O.
Right arrow Articles by Marquet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quintela, O.
Right arrow Articles by Marquet, P.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2006;52:1346-1355.)
© 2006 American Association for Clinical Chemistry, Inc.


Drug Monitoring and Toxicology

Liquid Chromatography–Tandem Mass Spectrometry for Detection of Low Concentrations of 21 Benzodiazepines, Metabolites, and Analogs in Urine: Method with Forensic Applications

Oscar Quintela1,2, François-Ludovic Sauvage1, Fabienne Charvier1, Jean-Michel Gaulier1, Gérard Lachâtre1 and Pierre Marquet1,a

1 Department of Pharmacology-Toxicology, Limoges University Hospital, Limoges, France.
2 Forensic Toxicology Department, Institute of Legal Medicine, University of Santiago de Compostela, C/San Francisco, Spain.

aAddress correspondence to this author at: Department of Pharmacology-Toxicology, Limoges University Hospital, 87042 Limoges, France. Fax 33-555-05-61-62; e-mail pierre.marquet{at}unilim.fr.

Background: Commonly used methods for detecting benzodiazepines (BZPs) and BZP-like substances, such as zolpidem and zopiclone, may not detect low concentrations of these drugs. We developed a liquid chromatographic–tandem mass spectrometric method for identifying these drugs and their relevant metabolites.

Methods: We extracted BZPs from urine by solid-phase extraction with a mixed-mode phase (OASIS® HLB cartridges). Chromatographic separation was performed with a Waters XTerra MS C18 [150 x 2.1 mm (i.d.); bead size, 5 µm] reversed-phase column with deuterated analogs of the analytes as internal standards (IS). Detection was performed with a triple-quadruple mass spectrometer that monitored 2 specific transitions per compound in the electrospray, positive-ion selected-reaction monitoring mode. We tested this technique on urine samples from 12 healthy volunteers and 1 forensic sample obtained in a case of alleged drug-facilitated sexual assault.

Results: Chromatographic separation was achieved within 18 min. The linear dynamic ranges extended from 0.02 or 0.1 µg/L (depending on the drug or metabolite) to 50 µg/L. Extraction recovery (range) was 77%–110%. Limits of detection were ≤0.05 µg/L. No ion suppression was seen except for alprazolam, for which baseline decreased by almost 20%. In the forensic urine sample, the method detected alprazolam (3.5 µg/L) and its characteristic metabolite, {alpha}-hydroxyalprazolam (0.17 µg/L).

Conclusion: This method measured low concentrations of BZPs and BZP-like substances and might be useful for analyses of urine in suspected drug-facilitated sexual assault cases.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
F.-L. Sauvage, J.-M. Gaulier, G. Lachatre, and P. Marquet
Pitfalls and Prevention Strategies for Liquid Chromatography-Tandem Mass Spectrometry in the Selected Reaction- Monitoring Mode for Drug Analysis
Clin. Chem., September 1, 2008; 54(9): 1519 - 1527.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.